Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment

Deciphering Developmental Disorders Study, SYNAPS Study Group

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.

Original languageEnglish
Pages (from-to)721-730
Number of pages10
JournalAmerican Journal of Human Genetics
Volume104
Issue number4
DOIs
Publication statusPublished - Apr 4 2019

Fingerprint

Vesicle-Associated Membrane Protein 2
SNARE Proteins
Synaptic Membranes
Membrane Fusion
Mutation
Neurotransmitter Agents
Synaptosomal-Associated Protein 25
Syntaxin 1
Hyperkinesis
Muscle Hypotonia
Synaptic Vesicles
Vision Disorders
Exocytosis
Movement Disorders
Human Development
Intellectual Disability
Electroencephalography
Epilepsy
Parturition
Phenotype

Keywords

  • autism
  • epilepsy
  • movement disorders
  • neurodevelopmental disorders
  • neuronal exocytosis
  • SNARE
  • synaptobrevin
  • synaptopathy
  • VAMP2
  • vesicle fusion

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment. / Deciphering Developmental Disorders Study; SYNAPS Study Group.

In: American Journal of Human Genetics, Vol. 104, No. 4, 04.04.2019, p. 721-730.

Research output: Contribution to journalArticle

Deciphering Developmental Disorders Study ; SYNAPS Study Group. / Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment. In: American Journal of Human Genetics. 2019 ; Vol. 104, No. 4. pp. 721-730.
@article{d7f9e67b3791443f90096c9a6805e447,
title = "Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment",
abstract = "VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.",
keywords = "autism, epilepsy, movement disorders, neurodevelopmental disorders, neuronal exocytosis, SNARE, synaptobrevin, synaptopathy, VAMP2, vesicle fusion",
author = "{Deciphering Developmental Disorders Study} and {SYNAPS Study Group} and Vincenzo Salpietro and Malintan, {Nancy T.} and Isabel Llano-Rivas and Spaeth, {Christine G.} and Stephanie Efthymiou and Pasquale Striano and Jana Vandrovcova and Cutrupi, {Maria Concetta} and Roberto Chimenz and Emanuele David and {Di Rosa}, Gabriella and Anna Marce-Grau and Miquel Raspall-Chaure and Elena Martin-Hernandez and Federico Zara and Carlo Minetti and Yamna Kriouile and {El Khorassani}, Mohamed and Mhammed Aguennouz and Blagovesta Karashova and Daniela Avdjieva and Hadil Kathom and Radka Tincheva and {Van Maldergem}, Lionel and Wolfgang Nachbauer and Sylvia Boesch and Larissa Arning and Dagmar Timmann and Bru Cormand and Belen P{\'e}rez-Due{\~n}as and Erica Pironti and Goraya, {Jatinder S.} and Tipu Sultan and Salman Kirmani and Shahnaz Ibrahim and Farida Jan and Jun Mine and Selina Banu and Pierangelo Veggiotti and Ferrari, {Michel D.} and Alberto Verrotti and Marseglia, {Gian Luigi} and Salvatore Savasta and Barbara Garavaglia and Carmela Scuderi and Eugenia Borgione and Valeria Dipasquale and Cutrupi, {Maria Concetta} and Simona Portaro and Sanchez, {Benigno Monteagudo}",
year = "2019",
month = "4",
day = "4",
doi = "10.1016/j.ajhg.2019.02.016",
language = "English",
volume = "104",
pages = "721--730",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment

AU - Deciphering Developmental Disorders Study

AU - SYNAPS Study Group

AU - Salpietro, Vincenzo

AU - Malintan, Nancy T.

AU - Llano-Rivas, Isabel

AU - Spaeth, Christine G.

AU - Efthymiou, Stephanie

AU - Striano, Pasquale

AU - Vandrovcova, Jana

AU - Cutrupi, Maria Concetta

AU - Chimenz, Roberto

AU - David, Emanuele

AU - Di Rosa, Gabriella

AU - Marce-Grau, Anna

AU - Raspall-Chaure, Miquel

AU - Martin-Hernandez, Elena

AU - Zara, Federico

AU - Minetti, Carlo

AU - Kriouile, Yamna

AU - El Khorassani, Mohamed

AU - Aguennouz, Mhammed

AU - Karashova, Blagovesta

AU - Avdjieva, Daniela

AU - Kathom, Hadil

AU - Tincheva, Radka

AU - Van Maldergem, Lionel

AU - Nachbauer, Wolfgang

AU - Boesch, Sylvia

AU - Arning, Larissa

AU - Timmann, Dagmar

AU - Cormand, Bru

AU - Pérez-Dueñas, Belen

AU - Pironti, Erica

AU - Goraya, Jatinder S.

AU - Sultan, Tipu

AU - Kirmani, Salman

AU - Ibrahim, Shahnaz

AU - Jan, Farida

AU - Mine, Jun

AU - Banu, Selina

AU - Veggiotti, Pierangelo

AU - Ferrari, Michel D.

AU - Verrotti, Alberto

AU - Marseglia, Gian Luigi

AU - Savasta, Salvatore

AU - Garavaglia, Barbara

AU - Scuderi, Carmela

AU - Borgione, Eugenia

AU - Dipasquale, Valeria

AU - Cutrupi, Maria Concetta

AU - Portaro, Simona

AU - Sanchez, Benigno Monteagudo

PY - 2019/4/4

Y1 - 2019/4/4

N2 - VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.

AB - VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.

KW - autism

KW - epilepsy

KW - movement disorders

KW - neurodevelopmental disorders

KW - neuronal exocytosis

KW - SNARE

KW - synaptobrevin

KW - synaptopathy

KW - VAMP2

KW - vesicle fusion

UR - http://www.scopus.com/inward/record.url?scp=85063684737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063684737&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2019.02.016

DO - 10.1016/j.ajhg.2019.02.016

M3 - Article

VL - 104

SP - 721

EP - 730

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 4

ER -